Praxbind (Boehringer Ingelheim Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Praxbind drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Humanized Monoclonal Antibody Fragment [EPC],Antibodies, Monoclonal, Humanized [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Boehringer Ingelheim Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: idarucizumab
SUBSTANCE NAME: IDARUCIZUMAB
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Humanized Monoclonal Antibody Fragment [EPC],Antibodies, Monoclonal, Humanized [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2015-10-21
END MARKETING DATE: 0000-00-00


Praxbind HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPraxbind from Boehringer Ingelheim Pharmaceuticals, Inc.
LABELER NAME: Boehringer Ingelheim Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/mL)
START MARKETING DATE: 2015-10-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0597-0197_979be189-6765-fb1a-e1a2-933fd93c3c3b
PRODUCT NDC: 0597-0197
APPLICATION NUMBER: BLA761025

Other IDARUCIZUMAB Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Boehringer Ingelheim Pharmaceuticals, Inc.Praxbind